Maud Camus-Ngo
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 15, 2025
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development.
Journal: Molecular cancer
Published: July 08, 2024
Codon-specific KRAS mutations predict survival in advanced pancreatic cancer.
Journal: ESMO gastrointestinal oncology
Published: January 24, 2024
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA.
Journal: Experimental hematology & oncology
Published: October 13, 2023
Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer.
Journal: Gastroenterology
Published: September 22, 2023
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.
Journal: European urology oncology
Published: July 21, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 06, 2022
Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 28, 2022
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 18, 2020
Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report.
Journal: JTO clinical and research reports
Published: February 16, 2020
Last Updated: 09/26/2026